The Role of GABA Co-release from Dopamine Neurons in Ethanol Consumption

NIH RePORTER · NIH · F31 · $38,431 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY Alcohol use disorder is a serious public health concern, yet its cause remains elusive; we still do not fully understand the neurophysiological mechanisms that drive EtOH consumption. All addictive drugs activate dopamine (DA) neurons, and this was assumed to only cause a synaptic increase of the neurotransmitter DA. However, recent evidence suggests that DA neurons also release the inhibitory neurotransmitter GABA, which equips DA neurons with another level of control over the striatum. Using transgenic mice, viral manipulations, and EtOH drinking behavior, the experiments proposed here will provide a mechanistic account of the role of GABA co-release from DA neurons in EtOH consumption. The results will also provide another level of mechanism – using two-photon imaging, optogenetics, and electrophysiology, the post-synaptic consequences of DA and GABA co-release on dendritic excitability will be defined. The mechanistic insight gained from these studies could inform novel treatment strategies for alcohol use disorder.

Key facts

NIH application ID
10116964
Project number
5F31AA027432-03
Recipient
STANFORD UNIVERSITY
Principal Investigator
Konstantin Kaganovsky
Activity code
F31
Funding institute
NIH
Fiscal year
2021
Award amount
$38,431
Award type
5
Project period
2019-03-01 → 2022-02-28